INMD vs AORT
Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
INMD · InMode$12.42 ▼ 2.20%
AORT · Artivion$18.16 ▼ 2.00%
One year, rebased to 100
Each line starts at 100 so growth is directly comparable
- INMD -10.1%
- AORT -60.4%
Head to head
| Metric | INMD | AORT |
|---|---|---|
| Price | $12.42 | $18.16 |
| Change today | ▼ 2.20% | ▼ 2.00% |
| Market cap | $714.70M | $886.02M |
| Return, 3 months | -17.7% | -32.5% |
| Return, year to date | -15.5% | -60.2% |
| Return, 1 year | -11.7% | -59.8% |
| P/E (TTM) | 10.4 | – |
| P/B | 1.1 | 2.0 |
| P/E percentile vs own 5y | 54th | 45th |
| Dividend yield | – | – |
| Revenue growth (YoY, latest qtr) | -1.1% | +9.2% |
| Net profit growth (YoY) | -13.7% | -221.9% |
| Gross margin | 76.6% | 63.3% |
| Operating margin | 17.6% | 1.6% |
| Net margin | 19.9% | -3.6% |
| Return on equity | 11.4% | -4.0% |
| Analyst target vs. price | +20.8% | +96.9% |
| Analyst buy share | 0% | 100% |
| RSI (14) | 31 | 33 |
| 30-day volatility | 30.8% | 82.5% |
| Max drawdown, 1 year | -25.3% | -61.9% |
| Trend read | Strong downtrend | Strong downtrend |
| Analyst consensus | Hold | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
What the numbers say
- AORT is the largest of the group by market value.
- INMD has returned the most over the past year.
- AORT is growing revenue fastest.
- INMD keeps the most profit per dollar of sales.
- INMD has been the calmest stock over the last 30 days.